Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
In the latest session, Precision Biosciences Inc (NASDAQ: DTIL) closed at $4.96 up 5.08% from its previous closing price of $4.72. In other words, the price has increased by $5.08 from its previous closing price. On the day, 0.18 million shares were traded. DTIL stock price reached its highest trading level at $5.05 during the session, while it also had its lowest trading level at $4.6364.
Ratios:
For a deeper understanding of Precision Biosciences Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 9.22 and its Current Ratio is at 9.22. In the meantime, Its Debt-to-Equity ratio is 0.47 whereas as Long-Term Debt/Eq ratio is at 0.45.
On April 30, 2024, Guggenheim started tracking the stock assigning a Buy rating and target price of $19.
On June 17, 2022, BMO Capital Markets started tracking the stock assigning a Outperform rating and target price of $7.BMO Capital Markets initiated its Outperform rating on June 17, 2022, with a $7 target price.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Dec 30 ’24 when Germano Geno J bought 3,605 shares for $4.49 per share. The transaction valued at 16,186 led to the insider holds 7,807 shares of the business.
Buehler Kevin bought 4,320 shares of DTIL for $21,082 on Dec 27 ’24. The Director now owns 8,712 shares after completing the transaction at $4.88 per share. On Dec 27 ’24, another insider, Kelly John Alexander, who serves as the Chief Financial Officer of the company, bought 2,113 shares for $4.75 each. As a result, the insider paid 10,037 and bolstered with 40,186 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, DTIL now has a Market Capitalization of 38048456 and an Enterprise Value of -32846548. As of this moment, Precision’s Price-to-Earnings (P/E) ratio for their current fiscal year is 97.06. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.52 while its Price-to-Book (P/B) ratio in mrq is 0.57. Its current Enterprise Value per Revenue stands at -0.437 whereas that against EBITDA is 2.742.
Stock Price History:
The Beta on a monthly basis for DTIL is 1.48, which has changed by -0.5555556 over the last 52 weeks, in comparison to a change of 0.23631513 over the same period for the S&P500. Over the past 52 weeks, DTIL has reached a high of $19.43, while it has fallen to a 52-week low of $3.61. The 50-Day Moving Average of the stock is -17.91%, while the 200-Day Moving Average is calculated to be -46.41%.
Shares Statistics:
For the past three months, DTIL has traded an average of 471.44K shares per day and 2239350 over the past ten days. A total of 7.48M shares are outstanding, with a floating share count of 3.73M. Insiders hold about 8.28% of the company’s shares, while institutions hold 81.17% stake in the company. Shares short for DTIL as of 1735603200 were 306659 with a Short Ratio of 0.65, compared to 1732838400 on 269482. Therefore, it implies a Short% of Shares Outstanding of 306659 and a Short% of Float of 4.0599998.
